Virus World
377.4K views | +28 today
Follow
Virus World
Virus World provides a daily blog of the latest news in the Virology field and the COVID-19 pandemic. News on new antiviral drugs, vaccines, diagnostic tests, viral outbreaks, novel viruses and milestone discoveries are curated by expert virologists. Highlighted news include trending and most cited scientific articles in these fields with links to the original publications. Stay up-to-date with the most exciting discoveries in the virus world and the last therapies for COVID-19 without spending hours browsing news and scientific publications. Additional comments by experts on the topics are available in Linkedin (https://www.linkedin.com/in/juanlama/detail/recent-activity/)
Curated by Juan Lama
Your new post is loading...
Scooped by Juan Lama
Scoop.it!

Survival of SARS-CoV-2 and Influenza Virus on the Human Skin

Survival of SARS-CoV-2 and Influenza Virus on the Human Skin | Virus World | Scoop.it

The stability of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on human skin remains unknown, considering the hazards of viral exposure to humans. We generated a model that allows the safe reproduction of clinical studies on the application of pathogens to human skin and elucidated the stability of SARS-CoV-2 on the human skin. We evaluated the stability of SARS-CoV-2 and influenza A virus (IAV), mixed with culture medium or upper respiratory mucus, on human skin surfaces and the dermal disinfection effectiveness of 80% (w/w) ethanol against SARS-CoV-2 and IAV.

 

SARS-CoV-2 and IAV were inactivated more rapidly on skin surfaces than on other surfaces (stainless steel/glass/plastic); the survival time was significantly longer for SARS-CoV-2 than for IAV [9.04 h (95% confidence interval: 7.96–10.2 h) vs. 1.82 h (1.65–2.00 h)]. IAV on other surfaces was inactivated faster in mucus versus medium conditions, while SARS-CoV-2 showed similar stability in the mucus and medium; the survival time was significantly longer for SARS-CoV-2 than for IAV [11.09 h (10.22–12.00 h) vs. 1.69 h (1.57–1.81 h)]. Moreover, both SARS-CoV-2 and IAV in the mucus/medium on human skin were completely inactivated within 15 s by ethanol treatment. SARS-CoV-2 and IAV were inactivated more rapidly on skin surfaces than on other surfaces (stainless steel/glass/plastic); the survival time was significantly longer for SARS-CoV-2 than for IAV [9.04 h (95% confidence interval: 7.96–10.2 h) vs. 1.82 h (1.65–2.00 h)]. IAV on other surfaces was inactivated faster in mucus versus medium conditions, while SARS-CoV-2 showed similar stability in the mucus and medium; the survival time was significantly longer for SARS-CoV-2 than for IAV [11.09 h (10.22–12.00 h) vs. 1.69 h (1.57–1.81 h)]. Moreover, both SARS-CoV-2 and IAV in the mucus/medium on human skin were completely inactivated within 15 s by ethanol treatment.

 

Published in Clinical Infectious Diseases  (Oct. 3, 2020):

https://doi.org/10.1093/cid/ciaa1517

No comment yet.
Scooped by Juan Lama
Scoop.it!

Anticipatory Immunity - Skin nerves can detect pathogens and activate an immune response against infection 

Anticipatory Immunity - Skin nerves can detect pathogens and activate an immune response against infection  | Virus World | Scoop.it

Mouse study reveals pain-sensing neurons also help fight skin infections and help prevent its spread. The findings suggest a new type of immunity. 

 

“These pain-sensing nerves can detect pathogens, and for the first time, we’ve shown that they activate an immune response and also signal protective immunity in sites adjacent to the infection,” said Daniel Kaplan, M.D., Ph.D., professor of dermatology and immunology at Pitt’s School of Medicine and the senior author of the study. “This demonstrates that the immune and nervous systems work synergistically for host defense. These findings also could have important implications for developing more specific therapies for autoimmune skin diseases like psoriasis.” 

 

Until about a decade ago, pain was thought to have evolved as a way for your body to tell you to stay away from a particular stimulus or to signal a problem with its function, like an injury. More recently, however, researchers have shown that it may play an important role in immunity against some pathogens.

In the study, Kaplan and first author Jonathan Cohen, an M.D./Ph.D. student in Kaplan’s lab, collaborated with Pitt neurobiology professors and pain experts Kathy Albers, Ph.D., and Brian Davis, Ph.D., to develop an optogenetic mouse model where pain-sensing neurons in the skin could be activated by shining blue light. They first showed that just activating these neurons released a small protein called CGRP, which recruited different types of immune cells to the site. This suggested that neurons detecting skin pathogens on their own kickstart an immune response even before sentry immune cells could.

 

Then in the same mouse model, they infected the animals with either Candida albicans, a fungus that causes candidiasis, commonly known as thrush, or Staphylococcs aureus, a common bacterium that can turn deadly under certain conditions. Using optogenetics and chemical nerve blockers, the researchers showed through a series of elegant experiments that when the fungus infected the skin at one location, the nerves not only detected and initiated an immune response to fight the infection, but also sent a signal toward the spinal cord. Those signals then boomeranged back to skin at areas around the infection to activate immune defenses in anticipation, thereby preventing the infection from spreading. The researchers called this new nerve-driven protective mechanism “anticipatory immunity.” 

 

“The advantage of involving the nervous system is that it can communicate information across a space in a span of milliseconds, compared to hours or days for the immune cells to do the same function,” said Jonathan Cohen, an M.D./Ph.D. student in Kaplan’s lab and the first author of the study.

 

Published on July 25 in the journal Cell:

https://doi.org/10.1016/j.cell.2019.06.022

Juan Lama's insight:

These studies utilized fungal and bacterial pathogens to demonstrate a role of nerve cells in innate immunity. It is possible that similar mechanisms may be elicited by other infectious agents such as viruses.

No comment yet.